论文信息 - Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study - 字舞流文

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study

A. Gasbarrini | M. Andreoni | M. Persico | G. Gualberti | A. Aghemo | R. Merolla | E. Villa | R. D’Ambrosio | V. Gallinaro | A. Bhagat